New Hampshire Trust has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity portfolio as of September 30, 2026. The report lists 277 distinct securities held by the firm, managed by President Cydney Shapleigh.
The filing details a portfolio that includes a mix of large-cap technology companies, healthcare giants, and financial institutions. Notable positions include significant holdings in Microsoft Corp, Nvidia Corp, and J.P. Morgan Chase & Co. The portfolio also includes substantial stakes in Procter & Gamble Co, Eli Lilly & Co, and Merck & Co Inc New.
International exposure is represented through holdings in companies such as ASML Hldgs NV NY ADR, Novartis AG ADR, and Qualcomm Inc. The report also lists various exchange-traded funds, including the iShares Core MSCI Emerging Mkts and the Invesco QQQ Trust.
